MPS5204
Drug discovery and development: The next step
基本信息
| 学分 | 6 credit points |
|---|---|
| 开课学期 | Second semester |
| 校区 | Malaysia |
| 考核构成 | Team pitch simulation — 15% Viva — 30% Project Portfolio — 40% Team-based written report — 15% |
开课安排1 条
| 教学期 | 授课方式 | 状态 |
|---|---|---|
| Second semester | Teaching activities are on-campus (ON-CAMPUS) | 开课 |
以上为该校区在官方资料中登记的全部开课安排，不是汇总。同一门课可能在多个 教学期开课，也可能不同教学期的授课方式不同。
课程简介
This unit takes you on a journey into real-life drug development challenges. The unit will utilise the target product profile (TPP) as the framework for exploring and understanding the challenges of translating a potential drug discovered at “the bench” into a registered medication for clinical use. Through a range of individual and group tasks, you will combine information and frameworks provided with your own inquiry to develop a holistic approach to evaluate the key milestones required for drug development, including the consideration of such things as intellectual property and patents, ethical and sustainable practices, regulatory considerations and financial factors. Cases will focus on modern drug discovery challenges and methodologies, including drug-repurposing development pathways, and will offer you the opportunity to present and interact with genuine pharmaceutical industry drug developers. You will present your evaluations via a variety of oral and written formats.
At the completion of the unit, you will have an extensive understanding of the key challenges of drug development and the purpose of a TPP, giving you a tool kit you can use to propose strategies for drug development and regulatory approval that you might encounter in your professional career.
以上为 Monash Handbook 的官方原文，版权属 Monash University，此处按本站要求转载并标注出处： 官方页面 ↗
学习成果5 条
官方原文（Learning outcomes），版权属 Monash University。
- ULO1 Critically investigate the process of modern drug development utilising the target product profile as a guiding framework
- ULO2 Present a logical and nuanced understanding of the impact of ethical and sustainable practices, regulatory considerations and financial factors on the development of new pharmaceutical products
- ULO3 Evaluate and report on how contemporary technologies and approaches can be used to expedite the development of novel pharmaceutical agents for existing diseases and those of emerging importance
- ULO4 Use effective oral communication to present and defend an informed evaluation of examples of drug development
- ULO5 Demonstrate effective teamwork practices within the context of a group report.
教学方式与预期工作量
教学方式
Active learning
Enquiry-based learning
Online learning
Case-based teaching
Peer assisted learning
预期工作量
• 24 hours of preparation for classes
• 22 hours of workshops
• 11 hours of applied sessions
• 72 hours of independent study
• 12 hours of group work
官方原文，版权属 Monash University。
先修 / 同修要求
官方资料未列出该课程的先修要求。
先修链路
官方资料未列出该课程的先修要求，因此没有链路可画。
属于这些学位1 个
这门课出现在下列学位的官方结构里。反过来说：如果你读的是这些学位之一，它大概率是要修的 （必修还是选修取决于它在 Part 里的位置，点进去看结构）。
数据来源
- 数据来源
- 官方网页
handbook.monash.edu ↗ - 抓取时间
- 2026-09-13
- 可信度
- 程序抓取，未人工核实
查看官方完整描述 ↗ — 事实性字段（代码、学分、教学期、授课方式、考核权重、先修/同修/互斥关系）与 课程简介、学习成果、教学方式、预期工作量均取自官方 Handbook； 正文版权属 Monash University，此处转载并逐处标注出处。
发现信息有误？告诉我们。请用自己的话描述问题，不要上传成绩单、截图或校内系统文件。